Prolongation of xenograft survival using monoclonal antibody CD45RB and cyclophosphamide in rat-to-mouse kidney and heart transplant models

Transplantation

Volumn 69, Issue 6, 2000, Pages 1137-1146

  Zhang, Zheng ^a,c   Lazarovitz, Andrew ^b   Gao, Zhuhua ^a   Garcia, Bertha ^b   Jiang, Jifu ^a   Wang, Jiaojing ^b   Xing, Jing Jing ^a   White, Martin ^a   Zhong, Robert ^a,b,d  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c NORTHWESTERN UNIVERSITY   (United States)

^d LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY SPECIFICITY; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; GENETIC COMPLEMENTATION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; KIDNEY TRANSPLANTATION; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SURVIVAL TIME; XENOGRAFT; XENOTRANSPLANTATION;

EID: 0034719765     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200003270-00019     Document Type: Article

References (37)

1. McCurry KR, Kooyman DL, Alvarado CG, et al. Human complement regulatory proteins protect seine-to-primate cardiac xenografts from humoral injury. Nature Med 1995; 1: 423.
2. Parker W, Saadi S, Lin SS, Holzknecht ZE, Bustos M, Platt JL. Transplantation of discordant xenografts: a challenge revisited. Immunol Today 1996; 17: 373.
3. Cramer DV, Wu GD. The humoral response to xenografts. Xeno 1996; 4: 30.
4. Xu H, Gundry SR, Hancock WW, et al. Prolonged discordant xenograft survival and delayed xenograft rejection in a pig-to baboon orthotopic cardiac xenograft model. J Thorac Cardiovasc Surg 1998; 115: 1342.
5. Kozlowski T, Monroy R, Xu Y, et al. Anti-Gal (alpha)1-3 Gal antibody response to porcine bone marrow in unmodified baboons and baboons conditioned for tolerance induction. Transplantation 1998; 66: 176.
6. Zhong R, Tucker J, Grant D, et al. Long-term survival and functional tolerance of baboon to monkey kidney and liver transplantation: a preliminary report. Transplant Proc 1996; 28: 762.
7. Hasan R, Van den Bogaerde JB, Wallwork J, White DJG. Evidence that long-term survival of concordant xenografts is achieved by inhibition of antispecies antibody production. Transplantation 1992; 54: 408.
8. Zhong ZR, Lazarovits A. Monoclonal antibody against CD45RB for the therapy of rejection and autoimmune diseases. J Mol Med 1998; 76: 572.
9. Lazarovits AI, Poppema S, Zhang Z, et al. Prevention and reversal of renal allograft rejection by antibody against CD45RB. Nature 1996; 380: 717.
10. Zhang Z, Schlachta C, Duff J, Stiller C, Grant D, Zhong R. Improved techniques for kidney transplantation in mice. Microsurgery 1995; 16: 103.
11. Corry RJ, Winn HJ, Russell PS. Primarily vascularized allografts of hearts in mice: The role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation 1973; 16: 343.
12. Zhang Z, Zhu L, Quan D, et al. Pattern of liver, kidney, heart, and intestine allograft rejection in different mouse strain combinations. Transplantation 1996; 62: 1267.
13. June C, Bluestone J, Nadler L, et al. The B7 and CD28 receptor families. Immunol Today 1994; 15: 321.
14. Hale DA, Gottschalk R, Maki T, Monaco AP. Use of CTLA4-Ig in combination with conventional immunosuppressive agents to prolong allograft survival. Transplantation 1997; 64: 897.
15. Elwood ET, Larsen CP, Cho HR, et al. Prolonged acceptance of concordant and discordant xenografts with combined CD40 and CD28 pathway blockade. Transplantation 1998; 65: 1422.
16. Click R, Weisberg D, White J, et al. Rejection of rat skin xenografts by either murine CD4 or CD8 T cells. Transplantation 1994; 58: 1020.
17. Najarian JS. Overview of in vivo xenotransplantation studies: prospects for the future. Transplant Proc 1992; 24: 733.
18. Lu CY, Khair-El-Din T, Davidson IA, et al. Xenotransplantation. FASEB J 1994; 8: 1122.
19. Fukuzaki T, Gotoh M, Hasuike Y, et al. Nonvascularized islet xenograft rejection in a mouse-to-rat combination where the vascularized heart is rapidly rejected. Transplant Proc 1994; 26: 779.
20. Johnson E, Leventhal J, Dalmasso A, et al. Use of a novel CD11b/CD18 inhibitory agent in a C6-deficient rat to evaluate xenograft rejection. Transplant Proc 1996; 28: 728.
21. Fabre JW, Sunderland C, Williams A. Immunosuppressive properties of rabbit antibodies against a major glycoprotein restricted rat leukocyte membranes. Transplantation 1980; 30: 167
22. Zhang Z, Zhong R, Grant D, et al. Prevention and reversal of renal allograft rejection by monoclonal antibody to CD45RB in the mouse model. Transplant Proc 1995; 27: 389.
23. Zhang Z, Zhong R, Jiang J, et al. Prevention of heart allograft and kidney xenograft rejection by monoclonal antibody to CD45 RB. Transplant Proc 1997; 29: 1253.
24. Auersvald LA, Rothstein DM, Oliveira SC, et al. Indefinite islet allograft survival in mice after a short course of treatment with anti-CD45 monoclonal antibodies. Transplantation 1997; 63: 1355.
25. Gao Z, Zhong R, Jiang J, et al. Adoptive transferable tolerance induced by CD45RB monoclonal antibody. Am Soc Nephrol 1999; 10: 374.
26. Basadonna G, Auervald L, Khuong C, et al. Antibody-mediated targeting of CD45RB isoforms: a novel immunotherapeutic strategy. Proc Natl Acad Sci USA 1998; 95: 3821
27. Gao Z, Lazarovits A, Wang J, et al. Allograft tolerance induced by cyclophosphamide without prior inoculation using donor cells-immune suppression and redirection. Transplant Immunol, in press.
28. Isobe M, Suzuki J, Yamazaki S, Horie S, Okubo Y, Sekiguchi M. Assessment of tolerance induction to cardiac allograft by anti-ICAm-1 and anti-LFA-1 monoclonal antibodies. J Heart Lung Transplant 1997; 16: 1149.
29. Miwa S, Isobe M, Suzuki, J, et al. Effect of anti-intercellular adhesion molecule-1 and anti-leukocyte function associated antigen-1 monoclonal antibodies on rat-to-mouse cardiac xenograft rejection. Surgery 1997; 121: 681.
30. Bach FH, Winkler H, Ferran C, Hancock WW, Robson SC. Delayed xenograft rejection. Immunol Today 1996; 17: 379.
31. Bracy JL, Sachs DH, Iacomini J Inhibition of xenoreactive natural antibody production by retroviral gene therapy. Science 1998; 281: 1845.
32. Sperling A, Bluestone J The complexities of T cell co-stimulation: CD28 and beyond. Immunol Rev 1996; 153: 155
33. Kawai K, Shahian A, Mark T, et al. Skin allograft rejection in CD28-deficient mice.Transplantation 1996; 61: 352
34. Fryer J, Leventhal J, Dalmasso A, et al. Beyond hyperacute rejection. Accelerated rejection in a discordant xenograft model by adoptive transfer of specific cell subsets. Transplantation 1995; 59: 171
35. Lanie L. The role of natural killer cells in transplantation. Curr Opin Immunol 1995; 7: 626
36. Lin Y, Vandeputte M, Waer M. Natural killer cell- and macrophage-mediated rejection of concordant xenografts in the absence of T and B cell responses. J Immunol 1997; 158: 5658
37. Seebach JD and Waneck GL. Natural killer cells in xenotransplantation. Xenotransplantation 1997; 4: 201